%0 Journal Article %A Karandeep Singh %A Thomas S. Valley %A Shengpu Tang %A Benjamin Y. Li %A Fahad Kamran %A Michael W. Sjoding %A Jenna Wiens %A Erkin Otles %A John P. Donnelly %A Melissa Y. Wei %A Jonathon P. McBride %A Jie Cao %A Carleen Penoza %A John Z. Ayanian %A Brahmajee K. Nallamothu %T Validating a Widely Implemented Deterioration Index Model Among Hospitalized COVID-19 Patients %D 2020 %R 10.1101/2020.04.24.20079012 %J medRxiv %P 2020.04.24.20079012 %X Introduction The coronavirus disease 2019 (COVID-19) pandemic is straining the capacity of U.S. healthcare systems. Accurately identifying subgroups of hospitalized COVID-19 patients at high- and low-risk for complications would assist in directing resources.Objective To validate the Epic Deterioration Index (EDI), a predictive model implemented in over 100 U.S. hospitals that has been recently promoted for use in COVID-19 patients.Methods We studied adult patients admitted with COVID-19 to non-ICU level care at a large academic medical center from March 9 through April 7, 2020. We used the EDI, calculated at 15-minute intervals, to predict a composite adverse outcome of ICU-level care, mechanical ventilation, or death during the hospitalization. In a subset of patients hospitalized for at least 48 hours, we also evaluated the ability of the EDI (range 0-100) to identify patients at low risk of experiencing this composite outcome during their remaining hospitalization. We evaluated model discrimination and calibration using both raw EDI scores and their slopes.Results Among 174 COVID-19 patients meeting inclusion criteria, 61 (35%) experienced the composite outcome. Area under the receiver-operating-characteristic curve (AUC) of the EDI was 0.76 (95% CI 0.68-0.84). Patients who met or exceeded an EDI of 64.8 made up 17% of the study cohort and had an 80% probability of experiencing the outcome during their hospitalization with a median lead time of 28 hours from when the threshold was first exceeded to the outcome. Employing the EDI slope lowered the AUCs to 0.68 (95% CI 0.60-0.77) and 0.67 (95% CI 0.59-0.75) for slopes calculated over 4 and 8 hours, respectively. In a subset of 109 patients hospitalized for at least 48 hours and who had not experienced the composite outcome, 14 (13%) patients who never exceeded an EDI of 37.9 had a 93% probability of not experiencing the outcome throughout the rest of their hospitalization, suggesting low risk.Conclusion In this validation study, we found the EDI identifies small subsets of high- and low-risk patients with fair discrimination. These findings highlight the need for hospitals to carefully evaluate prediction models before widespread operational use among COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementTSV was supported by grant K23 HL140165 from the National Heart, Lung, and Blood Institute. JPD was supported by grant K12-HL138039 from the National Heart, Lung, and Blood Institute. MYW was supported by grant K23 AG056638 from the National Institute on Aging. MWS, JW, and BKN were supported by grant R01 LM013325-01 from the National Library of Medicine and by the Michigan Institute for Data Science. MWS was supported by grant K01 HL136687 from the National Heart, Lung, and Blood Institute.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data include protected health information from the University of Michigan and are not available for download. https://github.com/ml4lhs/edi_validation %U https://www.medrxiv.org/content/medrxiv/early/2020/04/29/2020.04.24.20079012.full.pdf